STOCK TITAN

Camden Natl Corp SEC Filings

CAC Nasdaq

Welcome to our dedicated page for Camden Natl SEC filings (Ticker: CAC), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.

This page provides access to U.S. Securities and Exchange Commission filings for Camden National Corporation (NASDAQ: CAC), a Maine‑incorporated bank holding company. Through these filings, investors can review the company’s official disclosures about its commercial banking and wealth management activities, financial performance, capital position, and corporate governance.

Camden National Corporation files a range of documents with the SEC, including Form 8‑K current reports that announce material events. Recent 8‑K filings referenced in the available information cover topics such as quarterly earnings releases, dividend declarations, investor presentations, and board succession changes. These filings often include or reference press releases that detail net income, loan and deposit levels, asset quality metrics, and capital ratios, as well as information about quarterly cash dividends on the company’s common stock.

In addition to current reports, investors can use this filings page to locate the company’s annual reports on Form 10‑K and quarterly reports on Form 10‑Q, which provide more extensive discussions of Camden National Corporation’s business model, risk factors, regulatory environment, and financial statements. For a bank holding company, these periodic reports are key sources for understanding loan portfolios, deposit funding, capital adequacy, and non‑interest income streams, alongside the risk and capital disclosures that accompany them.

Users can also review filings related to dividend actions and board changes, as reflected in 8‑K items on dividend declarations and director retirement and succession. Where applicable, insider transaction reports on Form 4 can be consulted to see equity transactions by directors and officers.

Stock Titan’s platform enhances these regulatory documents with AI‑powered summaries that highlight the main points of lengthy filings, helping readers quickly identify key financial and governance information. Real‑time updates from the SEC’s EDGAR system, combined with simplified explanations of complex forms such as 10‑K, 10‑Q, 8‑K, and Form 4, make it easier to follow Camden National Corporation’s regulatory reporting and its implications for the CAC stock.

Rhea-AI Summary

Camden National Corporation director Maxwell Raina acquired 357 shares of Camden National Corp common stock on 09/19/2025 at a price of $40.22 per share under the company’s 2022 Equity and Incentive Plan in lieu of director fees. Following the transaction, Raina beneficially owns 2,136.359 shares, a total that includes 19.758 shares added via the company’s dividend reinvestment program since the last filing. The Form 4 was filed individually and signed by a POA on 09/23/2025. The filing discloses a routine equity grant and dividend reinvestment activity by a director.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Lawrence J. Sterrs, a director of Camden National Corporation (CAC), reported a purchase of company common stock. On 09/19/2025 he acquired 195 shares at $40.22 per share under the company's 2022 Equity and Incentive Plan in lieu of director fees. After the transaction he beneficially owned 14,565.066 shares in total, which includes 18.468 shares added since the last filing through the company's dividend reinvestment program. The Form 4 was filed as a single reporting person and signed by a power of attorney on 09/23/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Camden National Corporation (CAC) director Larry K. Haynes acquired common stock on 09/19/2025. The Form 4 reports an acquisition of 357 shares at a price of $40.22 per share under the company's 2022 Equity and Incentive Plan and amendment in lieu of director fees. Following the transaction, Mr. Haynes beneficially owns 2,506.43 shares, which includes 22.032 shares received through the company’s dividend reinvestment program since the prior filing. The filing is a single-person Form 4 and was signed by a POA on 09/23/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

McCarthy Marie J, a director of Camden National Corp (CAC), acquired 372 shares of the company's common stock on 09/19/2025 at $40.22 per share under the company's 2022 Equity and Incentive Plan in lieu of director fees. Following the transaction, McCarthy beneficially owned 15,578.112 shares, which includes 168.238 shares added via the company's dividend reinvestment program since the last filing. The Form 4 was signed by a POA on 09/23/2025. The filing documents a routine equity award and dividend reinvestment activity by an insider rather than an open-market purchase or sale.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Carl John Soderberg, a director of Camden National Corporation (ticker: CAC), reported an acquisition of 394 common shares on 09/19/2025 at a price of $40.22 per share. The shares were issued under the Company’s 2022 Equity and Incentive Plan and were granted in lieu of director fees. Following the transaction, Soderberg beneficially owns 100,419.243 shares. The filing notes that 1,114.364 of those shares were acquired since the last filing through the company’s dividend reinvestment program.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
-
Rhea-AI Summary

Rebecca Hatfield, a director of Camden National Corporation (CAC), acquired 245 shares of the issuer's common stock on 09/19/2025 at a price of $40.22 per share. The purchase was made under Camden National Corporation's 2022 Equity and Incentive Plan and was issued in lieu of director fees. Following the transaction, the filing reports 7,177.06 shares beneficially owned by the reporting person. The Form 4 was signed by a power of attorney, Christopher G. Hutchinson, on 09/23/2025.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
insider
Rhea-AI Summary

Camden National Corporation announced that Lawrence J. Sterrs will retire from its Board of Directors effective December 31, 2025. Mr. Sterrs has been a director since 2015 and currently serves as Board Chair and as a member of the Compensation and Technology Committees while chairing the Corporate Governance & Risk Committee. The filing states his retirement is not due to any disagreement with management or the Board. The Board has appointed Marie J. McCarthy, a director since 2018 and current chair of the Compensation Committee, as Vice-Chair immediately and as Chair upon Mr. Sterrs' retirement, ensuring an orderly leadership succession.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-0.07%
Tags
current report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-- %
Tags
quarterly report
-
Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
-10.2%
Tags
current report
Rhea-AI Summary

Camden National Corporation (NASDAQ: CAC) filed an 8-K announcing its latest capital return action. Under Item 8.01, the Board declared a regular quarterly cash dividend of $0.42 per share. The distribution will be paid on July 31, 2025 to shareholders of record as of July 15, 2025. No other material events, financial results or strategic actions were disclosed. The filing also includes the related press release as Exhibit 99.1 and XBRL cover-page tags (Exhibits 101 and 104).

The dividend amount is unchanged from recent quarters, signalling management’s confidence in near-term earnings stability and continued emphasis on shareholder returns. However, because the announcement is routine and does not alter guidance or capital structure, the market impact is expected to be limited.

Rhea-AI Impact
Rhea-AI Sentiment
End-of-Day
1.06%
Tags
current report

FAQ

What is the current stock price of Camden Natl (CAC)?

The current stock price of Camden Natl (CAC) is $47.57 as of January 30, 2026.

What is the market cap of Camden Natl (CAC)?

The market cap of Camden Natl (CAC) is approximately 789.7M.
Camden Natl Corp

Nasdaq:CAC

CAC Rankings

CAC Stock Data

789.69M
16.57M
1.78%
73.89%
2.76%
Banks - Regional
National Commercial Banks
Link
United States
CAMDEN

CAC RSS Feed